title: Postinflammatory hyperpigmentation in patients with skin of color.
abstract: Postinflammatory hyperpigmentation (PIH) has posed a substantial challenge for patients with higher Fitzpatrick skin types, specifically types III to VI. Treatment modalities pose a number of limitations due to the number of treatments required, potential side effects, and overall efficacy. Fortunately, multiple therapies have been delineated that can be moderately to highly efficacious in treating PIH in patients with skin of color. This article will review some of these modalities and procedures for this common patient concern.
authors.affiliation: Department of Dermatology, University of Florida, Gainesville, USA.
authors.forename: Divya
authors.initials: D
authors.lastname: Shokeen
mesh_terms: D006801:Humans; D002615:Chemexfoliation / Q000379:methods; D003872:Dermatitis / Q000150:complications; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000494:pharmacology; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004338:Drug Combinations; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology; D006016:Glycolates / Q000008:administration & dosage / Q000494:pharmacology; D006873:Hydroquinones / Q000008:administration & dosage / Q000494:pharmacology; D017495:Hyperpigmentation / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D007249:Inflammation / Q000150:complications; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000494:pharmacology; D019344:Lactic Acid / Q000008:administration & dosage / Q000494:pharmacology; D011753:Pyrones / Q000008:administration & dosage / Q000494:pharmacology; D012118:Resorcinols / Q000008:administration & dosage / Q000494:pharmacology; D012459:Salicylates / Q000008:administration & dosage / Q000494:pharmacology; D020156:Salicylic Acid / Q000008:administration & dosage / Q000494:pharmacology; D012880:Skin Pigmentation / Q000187:drug effects / Q000502:physiology; D014212:Tretinoin / Q000008:administration & dosage / Q000494:pharmacology; D000091762:Ethnic and Racial Minorities
chemical_list: C010038:azelaic acid; D003879:Dermatologic Agents; D003998:Dicarboxylic Acids; D004338:Drug Combinations; D000431:Ethanol; D006016:Glycolates; C031149:glycolic acid; C031927:hydroquinone; D006873:Hydroquinones; C061170:Jessner's solution; D007641:Keratolytic Agents; C011890:kojic acid; D019344:Lactic Acid; D011753:Pyrones; D012118:Resorcinols; D012459:Salicylates; D020156:Salicylic Acid; D014212:Tretinoin